Indirect CD133 MicroBead Kit, human

The Indirect CD133 MicroBead Kit was developed for positive selection or depletion of CD133+ cells, using a two-step procedure involving indirect magnetic labeling.

  • Hematopoietic stem cells can be isolated from peripheral blood, cord blood, bone marrow, or leukapheresis product.
  • Neural progenitor cells can be isolated from single-cell suspensions from primary neural tissues or cell lines.
  • ES and iPS cell–derived neural, endothelial, or hematopoietic progenitors can be isolated from differentiated ES or iPS cell cultures1.
  • Cancer st
... read more
qualityAssuranceSatisfaction
guaranteed
more »

Related products for Indirect CD133 MicroBead Kit, human

Product data and images for Indirect CD133 MicroBead Kit, human
Figure 1

Separation of non-mobilized PBMCs using CD133/1 (AC133)-Biotin, Anti-Biotin MicroBeads, MS Columns, and a MiniMACS™ Separator. The cells are fluorescently stained with CD34-FITC and CD133/2 (293C3)-PE. Cell debris and dead cells were excluded from the analysis based on scatter signals and PI fluorescence.

Specifications for Indirect CD133 MicroBead Kit, human
Overview

The Indirect CD133 MicroBead Kit was developed for positive selection or depletion of CD133+ cells, using a two-step procedure involving indirect magnetic labeling.

  • Hematopoietic stem cells can be isolated from peripheral blood, cord blood, bone marrow, or leukapheresis product.
  • Neural progenitor cells can be isolated from single-cell suspensions from primary neural tissues or cell lines.
  • ES and iPS cell–derived neural, endothelial, or hematopoietic progenitors can be isolated from differentiated ES or iPS cell cultures1.
  • Cancer stem cells can be isolated from single-cell suspensions from primary tumor tissue or cell lines.
Detailed product information
Background information

CD133, formerly known as AC133, recognizes epitope 1 of the CD133 antigen.2,3 It is a marker that is frequently found on multipotent progenitor cells, including immature hematopoietic stem and progenitor cells. In the hematopoietic system, CD133 is expressed on a small portion of CD34– cells4 as well as on a subset of CD34bright stem and progenitor cells in human fetal liver, bone marrow, cord blood, and peripheral blood5. CD133 has also been found to be expressed on circulating endothelial progenitor cells;6,7 fetal neural stem cells;8,9 other tissue-specific stem cells, such as renal10, prostate11, and corneal12 stem cells; cancer stem cells from tumor tissues; as well as ES and iPS cell-derived cells.

There is a growing interest in CD133 antigen expressing stem cells from normal blood or bone marrow in the field of regenerative medicine, for example bone marrow-derived CD133+ stem cells in cardiovascular13-17, liver, or peripheral artery diseases18-20.

The CD133 antibody included in the kit recognizes epitope CD133/1. For quality control staining of CD133-separated cells, the use of CD133/2 (293C3)-PE or -APC is recommended.

Downstream applications

Isolated from hematopoietic sources, CD133+ cells can become adherent and are reported to become CD133-negative during culture.21,22 These adherent cells can then in turn give rise to nonadherent CD133+ cells that are able to differentiate to both hematopoietic and nonhematopoietic cell types.23

CD133+ cells have shown a capacity for tissue differentiation, including to neural lineages24. CD133+ isolated from fetal liver25, umbilical cord blood26, bone marrow27, mobilized blood28, and skin29 are capable of in vitro differentiation to neuronal cells as well as to astrocytes,25,26,28 oligodendrocytes,26,28 and glial cells.26 CD133+ cells isolated from human fetal brain8,9,30-32 were able to form self-renewing neurospheres in vitro, and to differentiate into neurons8,32 and glia19,23. When injected into mice, human CD133+ cells differentiated into fully integrated neurones and glial cells9,30 as well as astrocytes and endothelial cells29. The CD34+CD133+ cell population, which includes CD34+CD38– cells, was shown to be capable of repopulating NOD/SCID mice33.

Columns

For positive selection: MS, LS, XS, or autoMACS® Columns. For depletion: LD, D, or autoMACS Columns.

Citations for Indirect CD133 MicroBead Kit, human
Publications
  1. Schulte am Esch 2nd, J. et al. (2005) Portal application of autologous CD133+ bone marrow cells to the liver: a novel concept to support hepatic regeneration. Stem Cells 23 (4): 463-470
  2. Jang, Y. K. et al. (2004) Retinoic acid-mediated induction of neurons and glial cells from human umbilical cord-derived hematopoietic stem cells. J. Neurosci. Res. 75: 573-584
  3. Klein, H. M. et al. (2007) Intramyocardial implantation of CD133+ stem cells improved cardiac function without bypass surgery. Heart Surg. Forum 10: E66-69
  4. Piechaczek, C. (2001) CD133. J. Biol. Regul. Homeost. Agents 15: 101-102
  5. Kuçi, S. et al. (2003) Identification of a novel class of human adherent CD34– stem cells that give rise to SCID-repopulating cells. Blood 101: 869-876
  6. Padovan, C. S. et al. (2003) Expression of neuronal markers in differentiated marrow stromal cells and CD133+ stem-like cells. Cell Transplant 12: 839-848
  7. Cañizo, M. C. et al. (2007) Peripheral endothelial progenitor cells (CD133+) for therapeutic vasculogenesis in a patient with critical limb ischemia. One year follow-up. Cytotherapy 9 (1): 99-102
  8. Bartunek et al. (2005) Circulation 30: 178-183
  9. Richardson, G. et al. (2004) CD133, a novel marker for human prostatic epithelial stem cells. J. Cell. Sci. 117: 3539-3545
  10. Klein (2007) Eur. Cardiovasc. Dis. 1: 123-125
  11. Uchida, N. et al. (2000) Direct isolation of human central nervous system stem cells. Proc. Natl. Acad. Sci. U.S.A. 97: 14720-14725
  12. Stamm, C. et al. (2007) Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies. J. Thorac. Cardiovasc. Surg. 133: 717-725
  13. de Wynter, E. A. et al. (1998) CD34+AC133+ cells isolated from cord blood are highly enriched in long-term culture-initiating cells, NOD/SCID-repopulating cells and dendritic cell progenitors. Stem Cells 16: 387-396
  14. Hao, H. N. et al. (2003) Fetal human hematopoietic stem cells can differentiate sequentially into neural stem cells and then astrocytes in vitro. J. Hematother. Stem Cell Res. 12: 23-32
  15. Thill, M. et al. (2004) Identification of a population of CD133+ precursor cells in the stroma of human cornea. Invest. Ophthalmol. Vis. Sci. 45: 3519
  16. Bussolati, B. et al. (2005) Isolation of renal progenitor cells from adult human kidney. Am. J. Pathol. 166: 545-555
  17. Kelly, S. et al. (2004) Transplanted human fetal neural stem cells survive, migrate, and differentiate in ischemic rat cerebral cortex. Proc. Natl. Acad. Sci. U.S.A. 101: 11839-11844
  18. Peichev, M. et al. (2000) Expression of VEGFR-2 and AC133 by circulating human CD34+ cells identifies a population of functional endothelial precursors. Blood 95: 952-958
  19. Piechaczek, C. et al. (2002) Differentiation of adult CD133+ cells isolated from peripheral blood into cells with a neural phenotype. Stem cell research (customer reports published by Miltenyi Biotec) : 2-3
  20. Gehling, U. M. et al. (2000) In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood 95: 3106-3112
  21. Stamm, C. et al. (2003) Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 4, 361 (9351): 45-46
  22. Tamaki, S. et al. (2002) Engraftment of sorted/expanded human central nervous system stem cells from fetal brain. J. Neurol. Res. 69: 976-986
  23. Gallacher, L. et al. (2000) Isolation and characterization of human CD34–Lin– and CD34+Lin– hematopoietic stem cells using cell surface markers AC133 and CD7. Blood 95 (ARVO Annual Meeting Abstract): 2813-2820
  24. Kuçi et al. (2004) 2nd Intl. Meeting, Stem Cell Network, North-Rhine Westphalia. : abstract
  25. Kuçi et al. (2003) MACS&more 7 (1): 6-8
  26. Yin, A. H. et al. (1997) AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 90: 5002-5012
  27. Bühring, H. J. et al. (1999) Expression of novel surface antigens on early hematopoietic cells. Ann. N. Y. Acad. Sci. 872: 25-39
  28. Kuçi, S. et al. (2008) Efficient in vitro generation of adult multipotent cells from mobilized peripheral blood CD133+ cells. Cell Prolif. 41: 12-27
  29. Galic, Z. et al. (2006) T lineage differentiation from human embryonic stem cells. Proc. Natl. Acad. Sci. U.S.A. 103: 11742-11747
  30. Fürst, G. et al. (2007) Portal vein embolization and autologous CD133+ bone marrow stem cells for liver regeneration: initial experience. J Immunother 243 (1): 171-179
  31. Belicchi, M. et al. (2004) Human skin-derived stem cells migrate throughout forebrain and differentiate into astrocytes after injection into adult mouse brain. J. Neurosci. Res. 77: 475-486
  32. Yu, S. et al. (2004) Isolation and characterization of the CD133+ precursors from the ventricular zone of human fetal brain by magnetic affinity cell sorting. Biotechnol. Lett. 26: 1131-1136
  33. Cummings, B. J. et al. (2005) Human neural stem cells differentiate and promote locometer recovery in spinal cord-injured mice. Proc. Natl. Acad. Sci. U.S.A. 102: 14069-14074

You have previously chosen International as your location.
What do you want to do?